News
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...
A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...
Learn 7 essential strategies for discussing migraines with your romantic partner. Build understanding and support in ...
Screen addiction, sleep disruption, and chronic stress are making migraines worse. Learn why modern life is a migraine ...
A 75% plus increase in good days/month with eptinezumab is associated with improved migraine symptoms, brain fog, and overall ...
A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...
Qasim Amin Nathari is on a mission to change the narrative around Chronic Migraine, particularly for Black men in America.
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...
Israel’s Teva Pharmaceutical Industries has announced that the final analysis of the pan-European PEARL Phase IV migraine ...
Erenumab significantly improved quality of life and disability among patients with chronic and episodic migraine over a 2-year period.
From a business perspective, migraine is a silent disruptor, says one expert, citing the damages caused by presenteeism ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results